Sinai Health says early research hints semaglutide-type drugs may ease inflammation apart from weight loss, and Ren is working out the mechanism.
Recap by typeshit. Post by Sinai Health on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
A 41-year-old and a 49-year-old died after cardiac arrest; one product appeared to come from 'research use only' seller AlphaLabs. The reports don't prove the drug caused the deaths.
TCTMD reports that two novel incretin-based agents looked highly effective in type 2 diabetes across a pair of new studies.
Loading…